Sam Raimi is no stranger to the box office. He has previously raked in millions for Marvel with his Spider-Man movies in the 2000s. He was able to do the same, if not elevate. His success when he took the helm for Doctor Strange In the Multiverse of Madness. The MCU film topped the box office for the third consecutive weekend, racking up $804 million in global receipts.
When the film was released, it was touted to be an underperforming addition to the Marvel films. Still, reality proved those claims wrong as it is on an unstoppable run that will inevitably top $900 million. Doctor Strange In the Multiverse of Madness may even have a chance to reach $1 billion.
The movie doesn’t have to reach the billion-dollar box office bar. It already established itself as a blockbuster and will likely generate a more elite-tier final cume. However, there were skeptical discussions regarding its performance only a week ago. The MCU is currently the only franchise. It has been able to hit the billion-dollar territory since the onset of the global pandemic. Since 2018, Disney has been the only studio to consistently generate over $1 billion. The only exception to this achievement was Warner Bros. DC film Joker in 2019.
Although 2022 is still halfway through, Doctor Strange In the Multiverse of Madness. It is already the highest-grossing movie worldwide and throughout the pandemic era. With a rating of 74% on Rotten Tomatoes, the Sam Raimi MCU film sits just behind Joss Whedon’s Avengers. Age of Ultron in the critical reception. However, the Cinemascore of B+ is below the MCU’s typical A-grade range.
Next weekend, Top Gun: Maverick seems to be positioned to replace Multiverse of Madness. But the repositioning will not be enough to deny the sorcerer supreme his next big box office milestone.
Doctor Strange In the Multiverse of Madness is projected to sit around $850+/- million. Once by close of business next weekend. From there, the film will take modest amounts for the coming weeks. Until it crosses the $900 million before ending its theatrical run.